(Q83007564)
Statements
[Twenty-four weeks therapy with peginterferon alfa-2a could be similar to 48 weeks therapy in patients with HBeAg positive chronic hepatitis B and good predictors of response: results of a pilot study] (English)
Joaquín Solari
Omar Galdame
Lucrecia Rezzonico
Bernardo Frider
Alejandra Villamil
Paola Casciato
Juan Carlos Bandi
Analía Alessio